Boston An independent LDT provider

Press releases

July 2, 2024

Immunovia’s new lab staffed and operational after rapid implementation

Read press release
June 19, 2024 | REGULATORY

BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)

Read press release
May 20, 2024 | REGULATORY

NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)

Read press release
May 20, 2024

Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans

Read press release
April 29, 2024

Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director

Read press release
April 29, 2024

Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina

Read press release
April 29, 2024 | REGULATORY

Immunovia publishes the annual report for 2023

Read press release
April 29, 2024 | REGULATORY

Immunovia Publishes Interim Report for January-March 2024

Read press release
April 23, 2024

Invitation to Immunovia’s Q1 presentation

Read press release
April 22, 2024

Immunovia announces updated financial calendar

Read press release
April 22, 2024

Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test

Read press release
April 9, 2024

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test – moving forward towards model-development study

Read press release
1 2 3 28